India generic drugs market is estimated to grow at a CAGR of nearly 9.5% during the forecast period. A significant rise in the incidences of chronic diseases is driving the demand for generic drugs in the country. The National Cancer Registry Programme estimates that there will be 13.9 lakh new cancer incidences reported in India in […]
Category Archives: Pharmaceuticals
Europe generic drugs market is estimated to grow at a CAGR of nearly 5.7% during the forecast period. European government initiatives to support generic producers are supporting to drive market growth. In May 2019, the European Union (EU) is taking measures to increase the competitiveness of EU manufacturers of generic drugs and biosimilar products. EU-based producers […]
Asia-Pacific generic drugs market is estimated to grow at a CAGR of nearly 8.0% during the forecast period. A significant rise in the prevalence of chronic diseases is the major factor accelerating the demand for generic medicines in the region. As per the estimation by the World Health Organization (WHO), the number of new cancer incidences […]
The global depression treatment Market is anticipated to grow at a CAGR of 4.1% during the forecast period (2021-2027). The increasing number of FDA approvals for antidepressants along with the expansion in pipeline products by key market players is certain factors driving the growth of the depression treatment industry. In February 2021, Zydus Cadila has […]
The European artificial tears market is anticipated to grow at a considerable CAGR of 4.6% during the forecast period (2021-2027). Due to rising DES (Dry Eye Syndrome), also known as Kerato Conjunctivitis Sicca, the demand for artificial tears is increasing in Europe. It is the most often multi-factorial disease of the ocular surface. Symptoms for […]
The global kidney cancer diagnostic and therapeutic market is projected to grow at a considerable CAGR of 6.8% during the forecast period (2021-2027). Kidney cancer is one of the most common cancer detected these days. The market growth is mainly attributed to high consumption of tobacco and smoking, hypertension, and obesity, the risk of kidney […]
Asia-Pacific anticoagulants market is estimated to grow at a CAGR of 7.8% during the forecast period. Researchers from the National Center for CVD in China have examined the prevalence and treatment of increased CVD risk in 1.7 million people from the China PEACE Million Persons Project. It is a Chinese government-funded project being conducted during […]
European anticoagulants market is estimated to grow at a CAGR of 6.6% during the forecast period. A significant rise in the demand for NOACs has been reported in the region, which in turn, is accelerating the market growth. The use of novel oral anticoagulants (NOACs) is growing significantly in Europe as their advantages over older […]
Indian anticoagulants market is estimated to grow at a CAGR of 8.8% during the forecast period. A significant rise in the demand for novel oral anticoagulants has been witnessed owing to its demonstrated safety and efficacy in trials and Indian government initiatives to reduce the prices of NOSCs. NOACs may be safer for patients as […]
UK anticoagulants market is estimated to grow at a CAGR of 7.0% during the forecast period. Significant incidences of atrial fibrillation and myocardial infarction are one of the major factors accelerating market growth. As per the British Heart Federation (BHF), in 2018, nearly 1.4 million people in the country have been diagnosed with atrial fibrillation […]